Drug: methotrexate Quarter: 2016Q3
Total Records: 3,574 Number of Pages: 179
| DRUGNAME | PT | EventCount |
|---|---|---|
| METHOTREXATE 2.5MG TABLET QUALITEST | Tremor | 1 |
| METHOTREXATE 25 MG FRESENIUS KABI USA, LLC FORMERLY APP PHARMACEUTICALS | Abnormal behaviour | 1 |
| METHOTREXATE 25 MG FRESENIUS KABI USA, LLC FORMERLY APP PHARMACEUTICALS | Disturbance in attention | 1 |
| METHOTREXATE 25 MG FRESENIUS KABI USA, LLC FORMERLY APP PHARMACEUTICALS | Restlessness | 1 |
| METHOTREXATE 25MG/ML 2 ML MDV HOSPIRA | Disturbance in attention | 1 |
| METHOTREXATE 25MG/ML 2 ML MDV HOSPIRA | Memory impairment | 1 |
| METHOTREXATE 25MG/ML ACCORD HEALTHCARE | Contusion | 1 |
| METHOTREXATE 25MG/ML ACCORD HEALTHCARE | Pyrexia | 1 |
| METHOTREXATE 25MG/ML ACCORD HEALTHCARE | Thrombocytopenia | 1 |
| METHOTREXATE 25MG/ML ACCORD HEALTHCARE | Tremor | 1 |
| METHOTREXATE 25MG/ML ACCORD HEALTHCARE | Vomiting | 1 |
| METHOTREXATE 25MG/ML APP | Aphonia | 1 |
| METHOTREXATE 25MG/ML APP | Nasal dryness | 1 |
| METHOTREXATE 25MG/ML APP | Sputum abnormal | 1 |
| METHOTREXATE 25MG/ML TEVA | Cough | 1 |
| METHOTREXATE 25MG/ML TEVA | Immunosuppression | 1 |
| METHOTREXATE 50 MG PER 2 ML TEVA | Cardiac failure | 1 |
| METHOTREXATE 50 MG PER 2 ML TEVA | Chronic obstructive pulmonary disease | 1 |
| METHOTREXATE 50 MG PER 2 ML TEVA | Dyspnoea | 1 |
| METHOTREXATE 50MG/2ML | Stomatitis | 1 |
Total Records: 3,574 Number of Pages: 179